ESR1 and triple-negative breast carcinoma: Triple-negative breast cancers (TNBCs) are tumors that lack expression of the estrogen receptor (ER), progesterone receptor (PR), and HER2, and account for approximately 15–20% of all diagnosed breast tumors [11].